Cancer treatment may inhibit immune response to COVID-19 vaccination
A study has found that patients with cancer who receive chemotherapy — and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells — may mount an inadequate immune response to COVID-19 vaccination.
Materials provided by Mayo Clinic. Original written by Joe Dangor. Note: Content may be edited for style and length.
Source link aaaaa